Marizyme (Marizyme) Margin of Safety % (DCF Earnings Based) : N/A (As of Jun. 09, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Marizyme Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Marizyme's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of Marizyme's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, Marizyme's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marizyme's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marizyme's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Marizyme's Margin of Safety % (DCF Earnings Based) falls into.

Marizyme Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Marizyme's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Marizyme (Marizyme) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marizyme Inc (OTCPK:MRZM) » Definitions » Margin of Safety % (DCF Earnings Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

555 Heritage Drive, Suite 205, Jupiter, FL, USA, 33458

Website

https://www.marizyme.com

Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.

Executives

Braeden Lichti	10 percent owner	650 GEORGIA ST #3200, VANCOUVER A1 V6B4P7
Nilesh Umedbhai Patel	director	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Michael R Stewart	director	5 WALNUT GROVE DRIVE, STE 140, HORSHAM PA 19044
Harrison Ross	officer: Vice President of Finance	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Georgiy Kovalyov	officer: Chief Financial Officer	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
David Barthel	director, officer: Chief Executive Officer	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Bradley Richmond	officer: Acting VP of Finance	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Julie B. Kampf	director	14054 OLD CYPRESS BEND, PALM BEACH GARDENS FL 33410
Vithalbhai D Dhaduk	director	FNCB BANCORP, INC., 102 E. DRINKER ST., DUNMORE PA 18512
Neil J Campbell	director, officer: Chief Executive Officer	225 CHIMNEY CORNER LANE, SUITE 2001, JUPITER FL 33458
Very Donald Leroy Jr	officer: Executive Vice President	4 SILVERWHITE AVENUE, LITTLE SILVER NJ 07739
William Hearl	director	448 SALK CIRCLE, GAITHERSBERG MD 20878
Bruce Harmon	officer: Chief Financial Officer	316 DEL PRADO BLVD. S., SUITE 204, CAPE CORAL FL 33990
Catherine J. Pachuk	officer: Chief Science Officer	1033 N. JEAGA DR, JUPITER FL 33458
Satishchandran Chandrasekhar	officer: Chief Operating Officer	167 CARMELA COURT, JUPITER FL 33478